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I In nt tr ro od du uc ct ti io on n: :   Neutrophil gelatinase-associated lipocalin (NGAL) has been recently
proved useful in the quantitation of chronic kidney disease (CKD). The aim of the
study was to assess prevalence of CKD according to the Modification of Diet in Renal
Disease (MDRD), Cockcroft-Gault, and the Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) formulae in 412 patients with normal serum creatinine and
markers of kidney function/injury such as NGAL, cystatin C, and kidney injury
molecule-1 (KIM-1) in these patients in relation to age (below and over 65 years).
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   Material and methods: We included in the study 1005 pa  -
tients with coronary artery disease and normal serum creatinine. However,
markers of kidney function/injury were assessed in 412 patients. The NGAL, cystatin
C and KIM-1, were assessed using commercially available kits.
R Re es su ul lt ts s: :   Patients over 65 years had significantly lower estimated glomerular
filtration rate (eGFR) than their younger counterparts despite identical creatinine.
They also had significantly lower haematocrit, despite similar Hb, lower platelet
count, higher serum fibrinogen, higher systolic (SBP) and lower diastolic blood
pressure, higher serum NGAL and cystatin C, but similar urinary NGAL and KIM-1.
Serum NGAL correlated with age, haematocrit, leukocyte, platelet and erythrocyte
count, eGFR, creatinine, fasting glucose, HbA1c, fibrinogen, SBP, and diabetes
duration. In multiple regression analysis kidney function (eGFR, creatinine
clearance or creatinine), cystatin C and SBP were predictors of serum NGAL.
C Co on nc cl lu us si io on ns s: :   In our study we found a very high prevalence of CKD up to 61% in
elderly patients with coronary artery disease and normal serum creatinine.
Neutrophil gelatinase-associated lipocalin could be a sensitive marker of kidney
function, particularly in elderly patients with another risk factor for kidney
damage, i.e. hypertension.
K Ke ey y   w wo or rd ds s: : elderly, neutrophil gelatinase-associated lipocalin, cystatin C, glomerular
filtration rate, Chronic Kidney Disease Epidemiology Collaboration, hypertension,
coronary artery disease.
Introduction
Prevalence of chronic kidney disease (CKD) is about 10-16%, mainly
in the elderly [1]. According to Kidney Disease Outcomes Quality Initiative
C Co or rr re es sp po on nd di in ng g   a au ut th ho or r: :
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(K/DOQI) glomerular filtration rate (GFR) below 60
ml/min  is  associated  with  increased  risk  of
cardiovascular morbidity and mortality [2]. Kurtal
et al. [3] pointed out that estimated glomerular
filtration rate (eGFR) was better in predicting
kidney function than creatinine; however, it was
still  an  ideal  assessment  of  renal  function,
particularly in the elderly. They did acknowledge
that  in  the  elderly,  eGFR  below  45  ml/min
indicated a marked or severe decline in GFR, even
without creatinine calibration. Moreover, in the
very old population > 80 years of age performance
of both equations (Modification of Diet in Renal
Disease [MDRD] and Cockcroft-Gault) has not yet
been extensively studied against the gold standard
measurement of GFR. In Third National Health and
Nutrition Examination Survey (NHANES III) eGFR
(MDRD) below 60 ml/min was found in 11% of
subjects  over  65  years  without  concomitant
diabetes and hypertension, while only in 0.1% and
1.2% of subjects aged 20-39 and 40-59 years,
respectively, was MDRD below 60 ml/min [1]. In
a Japanese population of almost 100 000 subject
from Okinawa, in more than 80% of patients over
70  years  creatinine  clearance  was  below  60
ml/min [4]. Due to different formulae used (MDRD,
Cockcroft-Gault) results are not identical or even
similar in the same age groups studied [3, 5, 6].
The Cockcroft-Gault equation provided higher
estimates at younger ages, and lower estimates
at older ages (i.e. greater than 70 years) than
those obtained with the simplified MDRD formula
[7]. It should be mentioned that age over 65 years
is usually, but not always, associated with lowered
GFR [8, 9]. This may be due to the fact that there
are many other comorbidities which may influence
GFR [10, 11].
Estimation of GFR is used clinically to assess the
degree of kidney impairment and to follow the
course of the disease. The GFR is equal to the sum
of the filtration rates in all of the functioning
nephrons, giving a rough measure of their number.
Glomerular filtration rate cannot be measured
directly, but could be estimated from the urinary
clearance of an ideal filtration marker or gold
standard – inulin. The amount of inulin filtered at
the glomerulus is equal to the amount excreted in
the urine, which can be measured. However, inulin
is in short supply, expensive, and difficult to assay.
In addition, the classic protocol for measuring inulin
clearance  is  full  of  drawbacks:  continuous
intravenous infusion, multiple blood samples, and
bladder catheterization. Furthermore, various less
cumbersome methods for measuring clearance are
available such as alternative filtration markers
(iothalamate,  iohexol,  DTPA,  or  EDTA),  bolus
administration of the marker, spontaneous bladder
emptying, etc [12-14]. These methods are simpler,
but all have disadvantages limiting their application
in clinical practice and affecting the interpretation
of research studies.
Since creatinine is also an unreliable parameter
describing kidney function and true GFR is very
rarely assessed, due to the costly, cumbersome and
time-consuming procedure, the search for a new
and sensitive marker of kidney function is under
way. Neutrophil gelatinase-associated lipocalin
(NGAL) has recently been proved useful in the
quantitation of chronic kidney disease [15, 16]. The
ability to identify CKD may allow early imple  -
mentation of treatments that could arrest or delay
the progression of renal damage, enable effective
treatment of its complications, and reduce the risk
of drug-induced nephrotoxicity. Therefore, the aim
of the study was to assess prevalence of chronic
kidney disease using estimated GFR/crea  tinine
clearance  according  to  different  formulae  in 
412  patients  with  normal  serum  creatinine
undergoing percutaneous coronary interventions
in relation to age (below and over 65 years) as well
as markers of kidney function/injury such as NGAL,
kidney injury molecule-1 (KIM-1) and cystatin C in
this population.
Material and methods
We included in the study 1005 patients with
coronary  artery  disease  (confirmed  angio  gra  -
phically,  class  II/III  CCS)  and  normal  serum
creatinine (below 1.2 mg/dl, the upper normal
range in the central laboratory). The patients were
recruited pros  pectively for percutaneous coronary
intervention (PCI) from the Invasive Cardiology
Department. All patients were informed about the
aim of the study and gave their informed consent.
We excluded patients with pre-existing CKD, on
the basis of elevated serum creatinine and/or
history  of  kidney  disease,  i.e.  proteinuria,
erythrocyturia, etc. The study was approved by the
Medical University Ethic Committee. Data were
obtained from hospital clinical records. 
We  evaluated  the  patients’  basal  clinical
variables: demographic and risk factors, family
history in regard to coronary artery disease, history
of  myocardial  infarction,  serum  creatinine  on
admission, lipids, glucose, blood pressure, medi  -
cations. Serum creatinine was measured by the
standard laboratory method (Jaffe) in one central
laboratory. Haemoglobin, albumin, cho  lesterol and
serum creatinine were analysed by the standard
laboratory methods in the central laboratory at the
University Hospital. We assessed kidney function
according to the simplified MDRD formula [17] and
the Cockcroft-Gault formula [18]. Since recently
a new estimating equation for GFR, the Chronic
Kidney Disease Epidemiology Colla  boration (CKD-
EPI)  equation,  was  developed  [19],  we  also
Markers of kidney function in the elderly in relation to the new CKD-EPI formula for estimation of glomerular filtration rate660 Arch Med Sci 4, August / 2011
estimated GFR using this new formula. Staging of
CKD was defined according to DOQI guidelines [1].
The NGAL was evaluated in serum using com  -
mercially available ELISA from BIOPORTO (Gentofte,
Denmark).  Cystatin  C  was  estimated  using
a commercially available assay from BioVendor,
Czech  Republic.  Kidney  injury  molecule-1  was
assessed using commercially available kits from
uscnlife, Shanghai, China. All tests were performed
according to the manufacturer’s instruc  tions by the
same person. 
Data obtained were analysed using Statistica 7.0
com  puter  software  (Tulsa,  OK).  Data  were
expressed as means ± SD or %. The examination
of the distribution normality of variables was done
using  the  Shapiro-Wilk  W test.  Comparisons
between groups were done by ANOVA or ˇ2 test as
appropriate. Correlations between NGAL and other
variables  were  evaluated  by  Pearson’s  or
Spearman’s test as appropriate. Values of p < 0.05
were taken as statistically significant. Multiple
regression  analysis  was  used  to  determine
independent  factors  affecting  the  dependent
variable. Factors showing a linear correlation with
NGAL (p < 0.1) were included in the analysis.
Results
In the group of patients below 65 years with
normal serum creatinine according to the Cockcroft-
Gault formula, stage 3 CKD was found in 32%,
according to MDRD in 6%, and according to CKD-
EPI in 6% of patients below 65 years of age. Normal
eGFR,  i.e.  90-120  ml/min,  was  found  in  21%
(Cockcroft-Gault formula), 40% (MDRD) and 39%
(CKD-EPI). 
In the group of elderly patients (over 65 years)
with normal serum creatinine according to Cockcroft-
Gault, stage 3 CKD, i.e. GFR 30-59 ml/min, was found
in 61%, and stage 4 CKD (GFR 15-29 ml/min) in 4%
patients. Normal eGFR was found in 7% of patients
older than 65 years. According to MDRD, stage 3
was diagnosed in 19%, while normal eGFR was
diagnosed in 21% of patients older than 65 years.
According to CKD-EPI, stage 3 was diagnosed in
19% of patients over 65 years of age, stage 4 in 1%,
and normal eGFR in 21% of this population. They
had significantly lower haematocrit, despite similar
Hb, lower platelet count, higher serum fibrinogen,
higher systolic and lower diastolic blood pressure
(Table  I).  Patients  over  65  years  of  age  had
significantly lower eGFR (MDRD, CKD-EPI, Cockcroft-
Gault formulae) than their younger counterparts
despite identical serum creatinine and significantly
higher serum NGAL and cystatin C, but similar
urinary NGAL (Table II). Serum NGAL correlated with
age (r = –0.27, p < 0.001) (Figure 1), haematocrit 
(r = –0.24, p < 0.001), haemoglobin (r = –0.12, 
p < 0.01), leukocyte (r = –0.15, p < 0.01), platelet 
P Pa ar ra am me et te er rs s A Ag ge e   < <   6 65 5   y ye ea ar rs s A Ag ge e   > >   6 65 5   y ye ea ar rs s V Va al lu ue e   o of f   p p
Age [years] 56.22 ±6.02 77.74 ±4.71 < 0.001
BMI [kg/m2] 29.53 ±4.72 28.87 ±4.52 > 0.05
RBC [× 1012/l] 4.63 ±0.47 4.89 ±0.51 < 0.01
Hb [g/dl] 13.98 ±1.32 13.68 ±2.82 > 0.05
Hct [%] 41.29 ±4.01 39.97 ±4.18 < 0.001
Platelets [× 106/l] 234.07 ±63.6 215.38 ±58.13 < 0.001
WBC [× 106/l] 7.60 ±2.18 7.42 ±2.6 > 0.05
Total cholesterol [mg/dl] 169.91 ±44.1 162.21 ±39.8 > 0.05
LDL cholesterol [mg/dl] 98 ±36.6 92.1 ±34.86 > 0.05
HDL cholesterol [mg/dl] 42.42 ±11.87 42.9 ±12.3 > 0.05
Triglycerides [mg/dl] 152.8 ±111.18 139.9 ±77.99 > 0.05
Glucose [mg/dl] 114.46 ±40.57 112.7 ±41.66 > 0.05
Insulin [mIU/l] 15.77 ±29.86 10.25 ±5.58 > 0.05
HbA1c [%] 6.36 ±1.11 6.46 ±1.23 > 0.05
Fibrinogen [mg/dl] 396.9 ±88.13 428.67 ±91.04 < 0.001
Systolic BP [mmHg] 125.68 ±17.69 132.3 ±19.81 < 0.001
Diastolic BP [mmHg] 75.96 ±11.05 72.96 ±10.8 < 0.01
EF [%] 47.79 ±11.15 47.42 ±10.14 > 0.05
T Ta ab bl le e   I I. . Clinical characteristics of the 412 patients with normal serum creatinine undergoing primary coronary
interventions in regard to age
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(r = 0.11, p < 0.05) and erythrocyte count (r = –0.18,
p < 0.001), eGFR/estimated creatinine clearance
(eCrCl) (MDRD, r = –0.48, p < 0.001), CKD-EPI 
(r = –0.52, p < 0.001, Figure 2), Cockcroft-Gault, 
r = –0.41, p < 0.001), serum creatinine (r = 0.49, 
p < 0.001), fasting glucose (0.18, p < 0.01), HbA1c
(r = 0.13, p < 0.05), fibrinogen (r = 0.35, p < 0.001),
NYHA class (r = 0.28, p < 0.001), SBP (r = 0.22, 
p < 0.01), diabetes duration (r = 0.21, p < 0.05),
urinary  NGAL  (r =  0.41,  p  <  0.001),  serum 
cystatin C (r = 0.58, p < 0.001, Figure 3), and urinary
KIM-1 (r = 0.13, p < 0.05).
In the model of multiple regression analysis
parameters  which  correlated  or  tended  to
correlate with NGAL (p < 0.1) were included (age,
haema  tocrit, leukocyte count, platelet count,
eGFR/eCrCl  or  serum  creatinine,  fasting
glucose/HbA1c, fibrinogen, NYHA class, cystatin C,
duration of diabetes, duration of hypertension,
urinary  NGAL,  urinary  KIM-1,  systolic  blood
pressure). In multiple regression analysis kidney
function  (either  eGFRʲ value  was  –0.38, 
p = 0.0003, or serum creatinine ʲ value was 0.33,
p  =  0.003),  cystatin  C  (ʲ value  was  0.23, 
p = 0.017) and systolic blood pressure (ʲ value
0.18, p = 0.05) were predictors of serum NGAL,
explaining  77%  of  NGAL  variation,  F  =  9.71, 
SE = 22.57.
I Im mp pa ac ct t   o of f   d di ia ab be et te es s, ,   h hy yp pe er rt te en ns si io on n   a an nd d   g ge en nd de er r
o of f   e el ld de er rl ly y   p pa at ti ie en nt ts s   o on n   s se er ru um m   n ne eu ut tr ro op ph hi il l
g ge el la at ti in na as se e- -a as ss so oc ci ia at te ed d   l li ip po oc ca al li in n
Normotensive elderly patients had significantly
lower NGAL (106 ±22.8 ng/ml vs. 129.6 ±47.0 ng/ml, 
p < 0.05) than hypertensives. Despite similar serum
creatinine levels, eGFR/eCrCl was significantly higher
in normotensives (p < 0.05) than in hyper  tensives.
Serum NGAL was significantly higher in diabetics
than in non-diabetics (132.12 ±50.21 ng/ml vs. 94.56 
±55.21 ng/ml, p < 0.05), whereas creatinine did not
differ significantly between these groups. Females
had lower eGFR (MDRD and CKD-EPI formulae) and
eCrCl relative to males (MDRD 54.89 ±21.61 ml/min
vs. 73.21 ±20.98 ml/min, p < 0.01, Cockcroft-Gault
48.11  ±18.79  ml/min  vs.  61.35  ±17.87  ml/min, 
p < 0.05, CKD-EPI 54.76 ml/min ±20.45 vs. 71.69
±18.19 ml/min, p < 0.01).
Patients over 65 years of age had statistically
significantly lower diastolic blood pressure, lower
body mass index (BMI), higher serum urea, and
lower eGFR/creatinine clearance (all formulae)
P Pa ar ra am me et te er rs s A Ag ge e   < <   6 65 5   y ye ea ar rs s A Ag ge e   > >   6 65 5   y ye ea ar rs s V Va al lu ue e   o of f   p p
Creatinine [mg/dl] 1.05 ±0.61 1.07 ±0.33 > 0.05
MDRD formula [ml/min] 84.11 ±19.76 71.18 ±20.21 < 0.001
CKD-EPI formula [ml/min] 84.52 ±18.21 67.58 ±18.41 < 0.001
C-G formula [ml/min] 100.39 ±27.74 67.91 ±21.48 < 0.001
NGAL – serum [mg/ml] 60.51 ±27.11 78.21 ±35.78 < 0.001
NGAL – urine [mg/ml] 16.19 ±14.87 17.01 ±21.76 > 0.05
Cystatin C – serum [mg/l] 0.97 ±0.45 1.20 ±0.43 < 0.001
Urinary KIM-1 [mg/ml] 45.96 ±32.69 50.97 ±46.54 > 0.05
T Ta ab bl le e   I II I. . Kidney function of the 412 patients with normal serum creatinine undergoing primary coronary interventions
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despite similar serum creatinine. The prevalence of
CKD, based on the National Kidney Foundation
Kidney  Disease  Outcome  Quality  Initiative
(NKF/DOQI) guidelines, was higher in the elderly.
However, prevalence of diabetes (20% vs. 30%, 
p < 0.05), dyslipidaemia (28% vs. 63%, p < 0.001),
positive family history of cardiovascular diseases
(91% vs. 42%, p < 0.001), past myocardial infarction
(14% vs. 20%, p < 0.05) and smoking (24% vs. 84%,
p < 0.001) was significantly lower than in their
younger  counter  parts  (below  65  years),  while
hypertension was more prevalent in older patients
(higher systolic blood pressure with lower diastolic
blood pressure) (73% vs. 59%, p < 0.01).
Discussion
Kidney function declines with years; however,
the important problem remains the assessment of
kidney  function  in  the  elderly.  Unfortunately,
creatinine is an unreliable parameter describing
kidney function [20]. First, using serum creatinine
to estimate true renal function has well-recognized
inaccuracies  and  limitations  [20].  A marked
reduction  in  GFR  can  be  present  before  it  is
reflected in a rise in serum creatinine (up to 50%
of kidney function has already been lost before
creatinine might change). Serum creatinine levels
can vary widely with age, gender, muscle mass,
muscle  metabolism,  medication  and  hydration
status.  In  the  Baltimore  Longitudinal  Study, 
254 healthy participants (without CKD, hyper  -
tension, not treated with diuretics) had periodic
assessment of creatinine clearance during the
period 1958-1981 [21]. Mean decrease in creatinine
clearance was 0.75 ml/min/year, and was greater
in  patients  who  developed  hypertension  later
during observation. In 1/3 there was no fall in
creatinine clearance. In all the formulae used to
estimate GFR, including the recent one i.e. CKD-EPI,
age is included; however, so far there are no data
on validation of them in the elderly population.
Within the 5th and 95th percentile for age, both
Cockcroft-Gault and MDRD formulae provide similar
measurements, which were consistent with age-
specific historic inulin clearance values [1]. The
Cockcroft-Gault equation provided higher estimates
at younger ages, and lower estimates at older ages
(i.e. greater than 70 years) than those obtained with
the simplified MDRD formula [7]. Stevens et al. [22]
reported in a meta-analysis on 5504 patients that,
for  those  with  an  initial  estimated  GFR  of 
60 ml/min per 1.73 m2 or greater, the median
difference between measured and estimated GFR
was 8.3 ml/min per 1.73 m2, which represents an
underestimation of GFR. This is due to the fact that
the MDRD formula was developed mainly in the
population with kidney disease and true GFR below
60  ml/min.  Compared  to  the  Cockcroft-Gault
equation however, the MDRD study equation that
is recalibrated for use with standardized creatinine
values provides more accurate estimates of the
glomerular filtration rate [23].
In a recent issue of Gerontology, Kurtal et al. [2]
reported that undiagnosed CKD was common in
the elderly. Moreover, in this study in about 52% of
the  prescribed  drugs  and  about  65%  of  all
prescribed drugs were those that needed dose
adjustment  or  should  be  avoided  in  renal
impairment. Since interventional cardiologists are
being asked to perform PCI on increasing numbers
of elderly patients with significant co-morbidities,
such as diabetes and/or renal insufficiency, contrast
nephropathy is a potentially serious complication
of PCI [24, 25]. Other risk factors also should be
taken  into  accounts  as  contributors  of  PCI
complications and adverse outcomes [26-29].
In  our  study,  we  found  that  serum  NGAL
correlated with kidney function/dysfunction in the
population studied. The strongest predictor of
serum NGAL was eGFR, indicating utility of NGAL
measurements  in  these  patients.  It  has  been
recently  reported  that  NGAL  could  represent
a marker of renal function in chronic kidney disease
in  children  [30]  and  adults  [12].  Neutrophil
gelatinase-associated  lipocalin  is  synthesized
systemically in response to kidney damage followed
by glomerular filtration and tubular uptake, and
could be produced locally by injured tubules. As
a small molecule NGAL is freely filtered by the
glomerulus, then is largely absorbed in the proximal
tubules by efficient megalin-dependent endocytosis
[31].  Mori  et  al. [32]  showed  that  a systemic
injection of labelled NGAL resulted in accumulation
of  NGAL  in  the  proximal  tubules  without
concomitant appearance in urine. Thus, NGAL
excretion in urine, in the situation of associated
proximal tubule injury, is likely to be due to NGAL
reabsorption  and/or  enhanced  de  novo NGAL
synthesis. In our study we did not find statistical
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vs. younger than 65 years. Our previous study
demonstrated  that  hypertensive  patients  had
significantly  higher  serum  NGAL  than  their
normotensive counterparts [33]. Our present study
is in line with this finding. In addition, in our recent
studies on heart transplant recipients, we found
that the prevalence of CKD in the elderly population
was as high as 81% (MDRD, CKD-EPI, creatinine
clearance)  to  100%  (Cockcroft-Gault  formula),
whereas  in  the  younger  population  of  heart
transplant recipients the prevalence of CKD ranged
from 56.3% to 77.5% [34]. Moreover, elderly heart
recipients had significantly higher cystatin C, serum
NGAL  and  lower  eGFR  than  their  younger
counterparts,  despite  not  having  statistically
different serum creatinine. Neutrophil gelatinase-
associated lipocalin was related to markers of
kidney function (eGFR, creatinine, cystatin C) in
heart transplant recipients [34, 35]. However, we
should bear in mind that NGAL is also found in
neutrophils.
The best predictor of NGAL was eGFR; thus we
should take into account the usefulness of NGAL
estimation in clinical practice. In the perspective of
the  development  of  urinary  [36]  or  whole
blood/plasma assays [37] for NGAL estimation,
a new tool for assessment of kidney function would
be available. The assay for the whole blood or
plasma is easy with quantitative results available
in 15 min and requires only microlitre sample [37].
Urinary assay requires only 150 µl of urine and the
results are available within 35 min [36].
The strengths of our study are simultaneous
measurement of urinary, serum NGAL, urinary 
KIM-1 and serum cystatin C, age- and sex-matching
for the populations over and below 65 years of age,
and use of the novel formula CKD-EPI, which better
determines eGFR in patients over 60 ml/min and
had validation for diabetes, age and transplantation
(although transplantation was not the case in this
setting). The limitations are that this study is single-
centre, cross-sectional, and on patients with normal
serum creatinine. Lack of GFR measurement may
also be a limitation; however, this procedure is
costly, cumbersome and generally not used for
clinical purposes, only for research.
Chronic kidney disease is an under-recognized
problem  in  geriatrics  and  eGFR  should  be
automatically reported, not only in geriatric units,
but in every unit, since our patients are getting
older, have more concomitant diseases, receive
more and more drugs and undergo more and more
potentially  nephrotoxic  invasive  procedures 
such as PCI or computed tomography with contrast
administration. Neutrophil gelatinase-associated
lipocalin should be investigated as a potential early
and sensitive marker of kidney impairment/injury.
Moreover, due to its sensitivity, NGAL may uncover
nephrotoxicity of new medications or procedures
in this vulnerable population of elderly patients.
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